We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 41-60 of 581 results
  1. Breast lesions associated with mammographic architectural distortion: a study of 588 core needle biopsies

    Architectural distortion (AD) on mammography is a localized alteration in the uniform texture of the breast characterized by lines radiating from a...

    S. Emily Bachert, Aaron Jen, ... Susan C. Lester in Modern Pathology
    Article 29 December 2021
  2. Association of current molecular subtypes in urothelial carcinoma with patterns of muscularis propria invasion

    Urothelial carcinoma is subdivided into luminal (L), basal (B), and p53-wild-type (WT) molecular subtypes, with basal and p53-WT groups showing more...

    Koorosh Haghayeghi, Shaolei Lu, ... Ali Amin in Virchows Archiv
    Article 04 July 2021
  3. Breast ductal Carcinoma in situ associated with microinvasion induces immunological response and predicts ipsilateral invasive recurrence

    Although microinvasion (Mi) is often thought to be an interim stage between ductal carcinoma in situ (DCIS) and established invasive ductal...

    Xiao-Yang Chen, Aye Aye Thike, ... Puay Hoon Tan in Virchows Archiv
    Article 02 November 2020
  4. Low-Grade Intraductal Carcinoma of the Parotid Gland: A Case Report and Literature Review

    Low-grade intraductal carcinoma is a rare neoplasia with an excellent prognosis, previously classified as low-grade cribriform cystadenocarcinoma and...

    Daniela Russo, Rosa Maria Di Crescenzo, ... Francesco Merolla in Head and Neck Pathology
    Article 27 January 2021
  5. Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan

    Objectives

    Enfortumab vedotin (EV) is a novel antibody–drug conjugate approved for metastatic urothelial carcinoma (UC) refractory to prior treatment...

    Yosuke Hirasawa, Takahiro Adachi, ... Yoshio Ohno in Journal of Cancer Research and Clinical Oncology
    Article Open access 09 April 2024
  6. Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer

    Purpose

    Currently, the most commonly applied method for the determination of breast cancer subtypes is to test estrogen receptor (ER), progesterone...

    Lili Chen, Yanyang Chen, ... Zunfu Ke in Breast Cancer Research and Treatment
    Article 05 July 2022
  7. Rare Breast Cancer Subtypes

    Purpose of Review

    Breast cancer is a collection of diseases including the more common invasive ductal and lobular carcinomas and rarer subtypes of...

    Sarah Jenkins, Megan E. Kachur, ... Stanley Lipkowitz in Current Oncology Reports
    Article 23 March 2021
  8. The sonographic findings of micropapillary pattern in pure mucinous carcinoma of the breast

    Background

    The aim of this study was to describe the sonographic features of pure mucinous carcinoma with micropapillary pattern (MUMPC) and compare...

    Heqing Zhang, Li Qiu, Yulan Peng in World Journal of Surgical Oncology
    Article Open access 24 July 2018
  9. Gastrectomy for invasive micropapillary carcinoma is associated with poorer disease-free and disease-specific survival

    Background

    Invasive micropapillary carcinoma (IMPC) is a relatively rare subtype of gastric adenocarcinoma and has aggressive histopathologic...

    Mikihiro Kano, Jun Hihara, ... Taijiro Sueda in International Journal of Clinical Oncology
    Article 20 July 2019
  10. High-risk lesions of the breast: concurrent diagnostic tools and management recommendations

    Breast lesions with uncertain malignant behavior, also known as high-risk or B3 lesions, are composed of a variety of pathologies with differing...

    Francesca Catanzariti, Daly Avendano, ... Maria Adele Marino in Insights into Imaging
    Article Open access 26 May 2021
  11. Breast carcinomas with osteoclast-like giant cells: a comprehensive clinico-pathological and molecular portrait and evidence of RANK-L expression

    Breast carcinomas (BC) with osteoclast-like giant cells (OGC) are rare. Despite their distinct stromal features, their molecular characteristics...

    Joanna Cyrta, Camille Benoist, ... Anne Vincent-Salomon in Modern Pathology
    Article Open access 13 June 2022
  12. Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent

    Ductal carcinoma in situ (DCIS) associated stromal changes and influx of immune cells might be mediators of progression to invasive breast cancer. We...

    Marie Colombe Agahozo, Pieter J. Westenend, ... Carolien H. M. van Deurzen in Modern Pathology
    Article 27 April 2020
  13. Salivary Intraductal Carcinoma Arising within Intraparotid Lymph Node: A Report of 4 Cases with Identification of a Novel STRN-ALK Fusion

    Intraductal carcinoma (IDC) is a rare salivary gland tumor that is considered analogous to ductal carcinoma in-situ of the breast, demonstrating a...

    Lisa M. Rooper, Lester D. R. Thompson, ... Justin A. Bishop in Head and Neck Pathology
    Article 13 July 2020
  14. Low-risk DCIS. What is it? Observe or excise?

    The issue of overdiagnosis and overtreatment of lesions detected by breast screening mammography has been debated in both international media and the...

    Sarah E. Pinder, Alastair M. Thompson, Jelle Wesserling in Virchows Archiv
    Article Open access 27 August 2021
  15. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type

    Intraductal carcinoma (IC) is a rare salivary gland tumor with low- to intermediate-grade cytological features. It is further classified into...

    Min-Shu Hsieh, Yi-Hsuan Lee, ... Ying-Ju Kuo in Virchows Archiv
    Article 07 May 2020
  16. Ductal Carcinoma In Situ—Pathological Considerations

    Purpose of Review

    Mammographic screening and radiological surveillance for local management has led to an exponential increase in diagnosis of ductal...

    Article 20 February 2020
  17. Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review

    Purpose

    Breast cancer (BC) is a leading cause of morbidity, disability, and mortality in women, worldwide; triple-negative BC (TNBC) is a subtype...

    D. Trapani, F. Giugliano, ... G. Curigliano in Breast Cancer Research and Treatment
    Article 27 May 2021
Did you find what you were looking for? Share feedback.